Myths vs facts: Helicobacter and blood sugar

The question of myths vs facts about Helicobacter pylori and blood sugar is nuanced. There is evidence that chronic H. pylori infection may promote insulin resistance and elevate blood glucose through systemic inflammation and gut microbiome alterations. Several observational studies report an association between H. pylori seropositivity and higher fasting glucose or type 2 diabetes risk. However, the evidence is not strong enough to establish causality. Randomized controlled trials on eradication therapy show mixed results: some indicate modest improvements in glycemic control, others find no significant effect. A common myth is that H. pylori directly metabolizes sugar or produces glucose – it does not. A fact is that untreated infection can cause gastritis and nutrient malabsorption (e.g., vitamin B12, iron), which may indirectly affect metabolism. Importantly, blood sugar dysregulation has many causes; H. pylori is only one potential contributor. Without gastrointestinal symptoms or risk factors, screening for H. pylori solely due to elevated blood sugar is not recommended. The evidence base is mixed – mechanistic and observational data exist, but no strong clinical guidelines support routine testing or treatment for glycemic purposes alone.